|
|
|
Press Releases
MILESTONE SCIENTIFIC EXPANDS GLOBAL SALES STRATEGY
TO ENHANCE PENETRATION OF INTERNATIONAL DENTAL MARKETS
LIVINGSTON, N.J. – (PR NEWSWIRE) – June 24,
2009 – Milestone Scientific Inc. (OTCBB:MLSS),
the recognized leader in advanced injection technologies, today announced
that it is refining its marketing strategy to gain greater access
to and penetration of the international dental markets for the STA
Single Tooth Anesthesia System™ (STA System), CompuDent® and
related disposable hand pieces.
The new sales strategy, led by Milestone Chairman and Interim CEO Leonard
Osser, will focus on increasing hands-on oversight and support of Milestone’s
existing international distribution network, while also attracting new
distributors throughout Europe, Asia and South America. To assist
in this endeavor, Milestone welcomes Shaul Koren, founder and CEO of
Istrodent Pty Ltd AB and one of Milestone’s strongest marketing
allies outside of the U.S., as its new international sales director,
who will help manage product sales for the Company in all non-domestic
markets worldwide.
“Our 10-year relationship with Shaul has proven to be highly beneficial
for Milestone,” noted Osser. “In many cases, it has
been through his introduction to leading distributors and industry influencers
in key international regions that has helped our Company to promote awareness
and adoption of Milestone’s growing portfolio of C-CLAD (Computer-Controlled
Local Anesthesia Delivery) solutions by dental professionals around the
world. Now tasked with heading up our new global expansion initiative,
Shaul, aided by a dedicated in-house sales support group at Milestone,
will work to inspire greater sales growth from each of our existing international
distributors; as well as work closely with our team to materially increase
the size, scope and impact of Milestone’s international distributor
network.”
“Driven by aging population, increasing demand for preventive
and cosmetic dental procedures and technological developments such
as our STA and CompuDent systems,
industry analysts are projecting that the global market for dental
supplies will exceed $21.8 billion by 2015 – up from $13 billion
in 2005,” continued Osser. “With an estimated 800,000
dentists practicing dentistry worldwide, more can and must be done
to reach and educate these professionals on the compelling practice
and patient benefits afforded by Milestone’s advanced injection
technologies; so, we intend to get even more proactive, adopting aggressive
marketing strategies to ensure that we optimize this high growth
opportunity.”
About Milestone Scientific Inc.
Headquartered in Livingston, New Jersey, Milestone Scientific is engaged
in pioneering proprietary, highly innovative technological solutions
for the medical and dental markets. Central to the Company’s
IP platform and product development strategy is its patented CompuFlo® technology
for the improved and painless delivery of local anesthetic. Specifically, CompuFlo is
a computer-controlled, pressure sensitive infusion, perfusion, suffusion
and aspiration technology, which provides real-time readouts of pressures,
fluid densities and flow rates, enabling the advanced delivery and
removal of a wide array of fluids. The STA Single
Tooth Anesthesia System™, a computer-controlled local anesthesia
delivery system, uses this technology to provide dentists with audible
and visual signals as to in-tissue pressure. Milestone’s
existing painless injection systems are currently sold in 25 countries. For
more information on these and other innovative Milestone products,
please visit the Company’s web site found at www.milestonescientific.com and www.STAis4U.com.
FOR MORE INFORMATION, PLEASE CONTACT:
Elite Financial Communications Group
Dodi Handy, President and CEO
For Media Inquiries: Tiffany Korkis or Kathy Addison, Directors, Elite
Media Group
407-585-1080 or via email at mlss@efcg.net
|
